Inclusion Criteria:  Marginally elevated low-density lipoprotein (LDL-C), 3.4 to 4.1 mmol/L Informed consent to the study and signed the informed consent form  Exclusion Criteria:  Patients who have a history of allergy to Pueraria Lobata or Pueraria Thomsonii. Patients who have taken lipid-lowering drugs within a week Patients with secondary dyslipidemia caused by other diseases or medications taken. Pregnant or lactating women. Patients who combine cognitive dysfunction, disorders of consciousness, psychiatric disorders, dyslexia or verbal communication dysfunction Patients with a combination of other serious diseases, such as malignant tumors, hepatic or renal insufficiency, cardiovascular or cerebrovascular disease, etc.